News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
SHERMAN JEFFREY W
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Disposed/sold 2,655 shares
@ $116.5, valued at
$309.3k
Disposed/sold 105,808 shares
@ $116.5, valued at
$12.3M
Disposed/sold 80,944 shares
@ $116.5, valued at
$9.4M
Disposed/sold 45,352 shares
@ $116.5, valued at
$5.3M
Disposed/sold 164,469 options to buy
@ $22.14, valued at
$3.6M
Disposed/sold 9,314 restricted stock units
@ $0
Disposed/sold 12,696 restricted stock units
@ $0
Disposed/sold 18,397 restricted stock units
@ $0
Disposed/sold 12,226 options to buy
@ $0
Disposed/sold 4,654 options to buy
@ $0
Disposed/sold 27,942 options to buy
@ $0 |
|
| 10/05/2023 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on Larimar Therapeutics, Inc.|
Txns:
| Granted 16,600 options to buy
@ $3.555, valued at
$59k
|
|
| 06/07/2023 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 42,500 shares
@ $0 |
|
| 01/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2023 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Sold 3,368 shares
@ $113.05, valued at
$380.8k
Sold 3,368 shares
@ $113.1, valued at
$380.9k
|
|
| 01/06/2023 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Paid exercise price by delivering 22,655 shares
@ $113.24, valued at
$2.6M
Sold 5,187 shares
@ $113.29, valued at
$587.6k
Granted 18,397 options to buy
@ $0
Exercised 12,095 options to buy
@ $0
Exercised 9,314 options to buy
@ $0
Exercised 6,348 options to buy
@ $0
Exercised 7,257 options to buy
@ $0
Exercised 1,966 options to buy
@ $0
Exercised 4,834 options to buy
@ $0
Exercised 9,318 options to buy
@ $0 |
|
| 01/04/2023 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Paid exercise price by delivering 9,717 shares
@ $113.8, valued at
$1.1M
Exercised 21,772 options to buy
@ $0 |
|
| 12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/08/2022 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Sold 42,009 shares
@ $110.021, valued at
$4.6M
|
|
| 03/21/2022 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Gifted 12,304 shares
@ $0
Gifted 12,304 shares
@ $0
Gifted 5,287 shares
@ $0
Gifted 5,287 shares
@ $0
Gifted 8,169 shares
@ $0
Gifted 8,169 shares
@ $0
Exercised 8,531 options to buy
@ $22.14, valued at
$188.9k
|
|
| 01/24/2022 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Paid exercise price by delivering 2,372 shares
@ $86.42, valued at
$205k
Exercised 5,354 options to buy
@ $0 |
|
| 01/06/2022 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Gifted 10,729 shares
@ $0
Gifted 10,729 shares
@ $0
Gifted 50 shares
@ $0
Granted 32,301 shares
@ $0
Paid exercise price by delivering 37,675 shares
@ $0
Granted 19,044 restricted stock units
@ $0
Exercised 12,261 restricted stock units
@ $0
Exercised 12,095 restricted stock units
@ $0
Exercised 9,222 restricted stock units
@ $0
Exercised 9,678 restricted stock units
@ $0
Exercised 9,314 restricted stock units
@ $0 |
|
| 10/29/2021 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Exercised 10,729 options to buy
@ $7.61, valued at
$81.6k
|
|
| 10/06/2021 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Disposed/sold 64,258 shares
@ $0
Disposed/sold 140,000 options to buy
@ $0 |
|
| 10/05/2021 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 50,378 shares
@ $0
Granted 47,040 options to buy
@ $6.66, valued at
$313.3k
Granted 31,360 options to buy
@ $5.62, valued at
$176.2k
Granted 31,360 options to buy
@ $9.89, valued at
$310.2k
Granted 19,650 options to buy
@ $12.5, valued at
$245.6k
Granted 20,000 options to buy
@ $10, valued at
$200k
Granted 11,228 options to buy
@ $4.68, valued at
$52.5k
Granted 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 10/05/2021 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 17,763 shares
@ $2.06, valued at
$36.6k
|
|
| 10/05/2021 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Disposed/sold 19,650 options to buy
@ $12.5, valued at
$245.6k
Disposed/sold 20,000 options to buy
@ $10, valued at
$200k
Disposed/sold 11,228 options to buy
@ $4.68, valued at
$52.5k
Disposed/sold 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 09/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/30/2021 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Granted 7,257 shares
@ $0
Paid exercise price by delivering 3,215 shares
@ $102.5, valued at
$329.5k
Granted 14,514 options to buy
@ $0 |
|
| 07/02/2021 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Gifted 66,730 shares
@ $0
Gifted 66,730 shares
@ $0
Sold 5,287 shares
@ $95, valued at
$502.3k
Sold 54,789 shares
@ $95.0026, valued at
$5.2M
|
|
| 06/08/2021 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 11,228 options to buy
@ $3.9, valued at
$43.8k
|
|
| 05/18/2021 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Granted 40,000 shares
@ $0 |
|
| 05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Gifted 8,679 shares
@ $0
Gifted 8,679 shares
@ $0
Paid exercise price by delivering 2,372 shares
@ $77.43, valued at
$183.7k
Exercised 5,353 options to buy
@ $0 |
|
| 01/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/09/2020 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Sold 36,389 shares
@ $70.31, valued at
$2.6M
Sold 16,200 shares
@ $71.52, valued at
$1.2M
Sold 10,489 shares
@ $72.24, valued at
$757.7k
Sold 9,631 shares
@ $70.6, valued at
$679.9k
Sold 31,133 shares
@ $71.32, valued at
$2.2M
|
|
| 10/21/2020 |
4
| SHERMAN JEFFREY W (EVP and Chief Medical Officer) has filed a Form 4 on Horizon Therapeutics Public Ltd Co|
Txns:
| Exercised 13,000 options to buy
@ $7.61, valued at
$98.9k
|
|
| 07/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2020 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 11,228 options to buy
@ $4.68, valued at
$52.5k
|
|
| 05/18/2020 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Paid exercise price by delivering 19,035 shares
@ $2.86, valued at
$54.4k
|
|
| 05/15/2020 |
4
| SHERMAN JEFFREY W (Director) has filed a Form 4 on Strongbridge Biopharma plc|
Txns:
| Granted 40,000 shares
@ $0 |
|
|
|
|